Leerink upgraded Galapagos (GLPG) to Outperform from Market Perform with a $40 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLPG:
- Galapagos NV to Wind Down Cell Therapy Business Following Strategic Review
- Galapagos intends to wind down cell therapy business
- Galapagos Appoints Fred Blakeslee as General Counsel
- Galapagos Updates on Cell Therapy Business Strategic Review
- Galapagos provides update on strategic alternatives for cell therapy business